Baucus hires Finance Committee health counsel
David Schwartz joins the Senate Finance Committee's Health and Welfare team as health counsel March 13 after serving three years as a fellow and then as a detailee from the Social Security Administration. His work on the committee will focus on issues related to pharmacies, drug pricing and benefits, health information technology, medical malpractice and the integrity of federal healthcare programs. Schwartz also will conduct investigations related to the operation of the Medicare and Medicaid programs...
You may also be interested in...
Roche/Genentech oncology partnering maintained a robust dealmaking pace through the pandemic, keeping the percentage of partnered R&D programs at about 50% of the cancer drug pipeline.
To mitigate pandemic disruption of component supply chains, the US FDA said it will downgrade some post-approval change categories for sterile drug container closure systems. The downgrade will cover drugs in shortage and those used to treat COVID-19.
“This is truly uncharted territory because we’ve never had this situation,” says CHPA regulatory VP David Spangle. Asking Congress instead to instruct FDA to first determine a safe daily limit would be a threatening precedent for the supplement market, says CRN CEO Steve Mister. “That really turns DSHEA on its head.”